156 related articles for article (PubMed ID: 38536861)
1. Predictors for participation in mass-treatment and female genital schistosomiasis re-investigation, and the effect of praziquantel treatment in South African adolescents.
Nemungadi TG; Kleppa E; Galappaththi-Arachchige HN; Pillay P; Gundersen SG; Vennervald BJ; Ndhlovu PD; Taylor M; Naidoo S; Kjetland EF
PLoS Negl Trop Dis; 2024 Mar; 18(3):e0011798. PubMed ID: 38536861
[TBL] [Abstract][Full Text] [Related]
2. Mapping Schistosoma haematobium for Novel Interventions against Female Genital Schistosomiasis and Associated HIV Risk in KwaZulu-Natal, South Africa.
Livingston M; Pillay P; Zulu SG; Sandvik L; Kvalsvig JD; Gagai S; Galappaththi-Arachchige HN; Kleppa E; Ndhlovu P; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
Am J Trop Med Hyg; 2021 May; 104(6):2055-2064. PubMed ID: 33939629
[TBL] [Abstract][Full Text] [Related]
3. Assessing urogenital schistosomiasis and female genital schistosomiasis (FGS) among adolescents in Anaocha, Anambra State, Nigeria: implications for ongoing control efforts.
Aribodor OB; Azugo NO; Jacob EC; Ngenegbo UC; Onwusulu ND; Obika I; Obikwelu EM; Nebe OJ
BMC Public Health; 2024 Apr; 24(1):952. PubMed ID: 38566137
[TBL] [Abstract][Full Text] [Related]
4. Absence of lower genital tract lesions among women of reproductive age infected with Schistosoma mansoni: A cross-sectional study using a colposcope in Western Kenya.
Sang HC; Mwinzi PNM; Odiere MR; Onkanga I; Rawago F; Pillay P; Kjetland EF
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010473. PubMed ID: 35802746
[TBL] [Abstract][Full Text] [Related]
5. The Association Between Female Genital Schistosomiasis and Other Infections of the Lower Genital Tract in Adolescent Girls and Young Women: A Cross-Sectional Study in South Africa.
Shukla JD; Kleppa E; Holmen S; Ndhlovu PD; Mtshali A; Sebitloane M; Vennervald BJ; Gundersen SG; Taylor M; Kjetland EF
J Low Genit Tract Dis; 2023 Jul; 27(3):291-296. PubMed ID: 37379442
[TBL] [Abstract][Full Text] [Related]
6. Female genital schistosomiasis due to Schistosoma haematobium. Clinical and parasitological findings in women in rural Malawi.
Kjetland EF; Poggensee G; Helling-Giese G; Richter J; Sjaastad A; Chitsulo L; Kumwenda N; Gundersen SG; Krantz I; Feldmeier H
Acta Trop; 1996 Dec; 62(4):239-55. PubMed ID: 9028409
[TBL] [Abstract][Full Text] [Related]
7. Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel.
Kjetland EF; Mduluza T; Ndhlovu PD; Gomo E; Gwanzura L; Midzi N; Mason PR; Friis H; Gundersen SG
Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):740-52. PubMed ID: 16406034
[TBL] [Abstract][Full Text] [Related]
8. Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel--an interim report.
Richter J; Poggensee G; Kjetland EF; Helling-Giese G; Chitsulo L; Kumwenda N; Gundersen SG; Deelder AM; Reimert CM; Haas H; Krantz I; Feldmeier H
Acta Trop; 1996 Dec; 62(4):289-301. PubMed ID: 9028413
[TBL] [Abstract][Full Text] [Related]
9. Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area.
Midzi N; Ndhlovu PD; Nyanga L; Kjetland EF; Reimert CM; Vennervald BJ; Gomo E; Mudenge G; Friis H; Gundersen SG; Mduluza T
Parasite Immunol; 2003; 25(11-12):581-8. PubMed ID: 15053779
[TBL] [Abstract][Full Text] [Related]
10. Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract.
Kleppa E; Ramsuran V; Zulu S; Karlsen GH; Bere A; Passmore JA; Ndhlovu P; Lillebø K; Holmen SD; Onsrud M; Gundersen SG; Taylor M; Kjetland EF; Ndung'u T
PLoS One; 2014; 9(6):e98593. PubMed ID: 24896815
[TBL] [Abstract][Full Text] [Related]
11. Association between cervical dysplasia and female genital schistosomiasis diagnosed by genital PCR in Zambian women.
Rafferty H; Sturt AS; Phiri CR; Webb EL; Mudenda M; Mapani J; Corstjens PLAM; van Dam GJ; Schaap A; Ayles H; Hayes RJ; van Lieshout L; Hansingo I; Bustinduy AL
BMC Infect Dis; 2021 Jul; 21(1):691. PubMed ID: 34273957
[TBL] [Abstract][Full Text] [Related]
12. Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women.
Kjetland EF; Ndhlovu PD; Mduluza T; Gomo E; Gwanzura L; Mason PR; Kurewa EN; Midzi N; Friis H; Gundersen SG
Am J Trop Med Hyg; 2005 Mar; 72(3):311-9. PubMed ID: 15772328
[TBL] [Abstract][Full Text] [Related]
13. The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi, Zimbabwe, Madagascar and South Africa.
Norseth HM; Ndhlovu PD; Kleppa E; Randrianasolo BS; Jourdan PM; Roald B; Holmen SD; Gundersen SG; Bagratee J; Onsrud M; Kjetland EF
PLoS Negl Trop Dis; 2014; 8(11):e3229. PubMed ID: 25412334
[TBL] [Abstract][Full Text] [Related]
14. "We know about schistosomiasis but we know nothing about FGS": A qualitative assessment of knowledge gaps about female genital schistosomiasis among communities living in Schistosoma haematobium endemic districts of Zanzibar and Northwestern Tanzania.
Mazigo HD; Samson A; Lambert VJ; Kosia AL; Ngoma DD; Murphy R; Matungwa DJ
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009789. PubMed ID: 34591872
[TBL] [Abstract][Full Text] [Related]
15. A review of female genital schistosomiasis.
Kjetland EF; Leutscher PD; Ndhlovu PD
Trends Parasitol; 2012 Feb; 28(2):58-65. PubMed ID: 22245065
[TBL] [Abstract][Full Text] [Related]
16. An update on female and male genital schistosomiasis and a call to integrate efforts to escalate diagnosis, treatment and awareness in endemic and non-endemic settings: The time is now.
Bustinduy AL; Randriansolo B; Sturt AS; Kayuni SA; Leustcher PDC; Webster BL; Van Lieshout L; Stothard JR; Feldmeier H; Gyapong M
Adv Parasitol; 2022; 115():1-44. PubMed ID: 35249661
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.
Ndeffo Mbah ML; Gilbert JA; Galvani AP
Epidemics; 2014 Jun; 7():22-7. PubMed ID: 24928666
[TBL] [Abstract][Full Text] [Related]
18. Urogenital schistosomiasis (UGS) and female genital schistosomiasis (FGS) in Cameroon: an observational assessment of key reproductive health determinants of girls and women in the Matta Health Area.
Makia CM; Fesuh NB; Amabo EN; Gamba VA; Oluwole AS; Stothard R
BMJ Open; 2023 Feb; 13(2):e063392. PubMed ID: 36787976
[TBL] [Abstract][Full Text] [Related]
19. Infection status and risk factors associated with urinary schistosomiasis among school-going children in the Ndumo area of uMkhanyakude District in KwaZulu-Natal, South Africa two years post-treatment.
Kabuyaya M; Chimbari MJ; Mukaratirwa S
Int J Infect Dis; 2018 Jun; 71():100-106. PubMed ID: 29679769
[TBL] [Abstract][Full Text] [Related]
20. Association of Urogenital Symptoms with History of Water Contact in Young Women in Areas Endemic for S. haematobium. A Cross-Sectional Study in Rural South Africa.
Galappaththi-Arachchige HN; Amlie Hegertun IE; Holmen S; Qvigstad E; Kleppa E; Sebitloane M; Ndhlovu PD; Vennervald BJ; Gundersen SG; Taylor M; Kjetland EF
Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27854250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
